Stay updated on BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial
Sign up to get notified when there's something new on the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page.

Latest updates to the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov page now shows a 403 Forbidden message in place of the clinical study details.SummaryDifference17%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe study page now displays a 403 Forbidden error, replacing the expected study record content with a standard error page. This indicates restricted access to the NCT05599191 page.SummaryDifference17%

- Check37 days agoChange DetectedThe page shows Revision: v3.6.6 instead of v3.6.5, indicating a new build of the site without changes to the study details.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page now includes expanded metadata signaling regulatory status (FDA-regulated drug and device) and data-sharing plans, plus added keywords/MeSH terms. It also includes PubMed publications, sponsor/investigator details, and updated record dates for better context and traceability.SummaryDifference100%

- Check58 days agoChange DetectedThe page revision tag was updated from v3.6.4 to v3.6.5, indicating a new release of the page. It reflects an administrative/UI version change rather than a modification to the study details.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a small backend or template update with no visible changes to the study information.SummaryDifference0.0%

Stay in the know with updates to BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BLU-5937 Efficacy and Safety in Refractory Cough Clinical Trial page.